scispace - formally typeset
I

Isabelle Soerjomataram

Researcher at International Agency for Research on Cancer

Publications -  201
Citations -  147827

Isabelle Soerjomataram is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 49, co-authored 166 publications receiving 83673 citations. Previous affiliations of Isabelle Soerjomataram include Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Alcohol and Cancer: Epidemiology and Biological Mechanisms

TL;DR: A review of the epidemiological evidence on alcohol and cancer risk and the mechanistic evidence of alcohol-mediated carcinogenesis is presented in this paper, where the authors discuss several mechanistic pathways by which the consumption of alcohol, as ethanol, is known to cause cancer, though some are still not fully understood.
Journal ArticleDOI

Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010

TL;DR: The control of CVD has led to substantial gains in LE40-84 worldwide and the inequality in improvement in longevity attributed to declining cancer mortality rates reflects inequities in implementation of cancer control, particularly in less resourced populations and in women.
Journal ArticleDOI

Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection

TL;DR: The methodologies for estimating, challenges in the analysis of, and utility of, population attributable and preventable fractions for cancers caused by major risk factors such as tobacco smoking, dietary factors, high body fat, physical inactivity, alcohol consumption, infectious agents, occupational exposure, air pollution, sun exposure, and insufficient breastfeeding are summarized.
Journal ArticleDOI

Second primary cancers in survivors of cervical cancer in The Netherlands: Implications for prevention and surveillance.

TL;DR: Cervical cancer survivors who underwent radiotherapy were at higher risk for a second tumor when compared to those without radiotherapy, especially at smoking-related sites, and smoking- and irradiation-related tumors.